Valuation : Evogene Ltd.

Market Cap 74.32L 0 63.8L 59.73L 54.69L 1.03Cr 71Cr 1.03Cr 7.07Cr 2.76Cr 36Cr 2.79Cr 2.73Cr 118.4Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 74.32L 0 63.8L 59.73L 54.69L 1.03Cr 71Cr 1.03Cr 7.07Cr 2.76Cr 36Cr 2.79Cr 2.73Cr 118.4Cr EV / Sales 2026 *
5.01x
EV / Sales 2027 * 2.86x
Free-Float
72.15%
Yield 2026 *
-
Yield 2027 * -
1 day-0.12%
1 week-5.62%
Current month+4.69%
1 month-4.57%
3 months-22.03%
6 months-38.29%
Current year-45.84%
1 week 161.2
Extreme 161.2
181.9
1 month 143.6
Extreme 143.6
229.8
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
478.7
3 years 115.1
Extreme 115.1
3,700
5 years 115.1
Extreme 115.1
10,430
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 01/12/2004
Corporate Officer/Principal - -
Corporate Officer/Principal - 01/01/2022
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 03/06/2010
Chairman 60 01/06/2021
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Buy

Director

4,60,000 2.9111%
04/08/26 Buy

Director

8,00,000 5.0628%
18/03/26 Other

Executive/Senior Manager

40,000 0.4588%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-5.62%-62.24%-94.01% 74.06L
+0.10%+1.59%+1.76%+24.32% 5.1TCr
+2.65%+4.45%+481.36%+585.52% 4.62TCr
-0.88%+0.90%+24.11%+84.32% 4.27TCr
+0.33%+2.47%+38.97%+18.30% 4.3TCr
-2.27%-3.02%+14.22%+51.50% 3.35TCr
-1.21%-0.17%+29.16%+133.74% 1.73TCr
-0.36%-2.14% - - 1.64TCr
+0.25%+3.31%+11.38%+30.68% 1.47TCr
+0.44%+1.70%+82.07%+49.13% 1.41TCr
Average +0.04%+0.65%+68.98%+98.17% 2.79TCr
Weighted average by Cap. +0.29%+1.16%+104.11%+144.18%

Financials

2026 *2027 *
Net sales 14.84L 0 12.74L 11.93L 10.92L 20.57L 14Cr 20.63L 1.41Cr 55.21L 7.14Cr 55.72L 54.51L 24Cr 26L 0 22.32L 20.89L 19.13L 36.04L 25Cr 36.15L 2.47Cr 96.72L 13Cr 97.62L 95.51L 41Cr
Net income -1.67Cr -0 -1.43Cr -1.34Cr -1.23Cr -2.31Cr -159.37Cr -2.32Cr -16Cr -6.21Cr -80Cr -6.27Cr -6.13Cr -265.84Cr -1.39Cr -0 -1.19Cr -1.12Cr -1.02Cr -1.93Cr -132.9Cr -1.93Cr -13Cr -5.18Cr -67Cr -5.22Cr -5.11Cr -221.68Cr
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
38
Date Price Change Volume
27/26/27 ILA 162.80 -0.12% 27,700
26/26/26 ILA 163.00 -3.49% 48,194
25/26/25 ILA 168.90 -2.26% 32,361
24/26/24 ILA 172.80 -0.29% 45,655
21/26/21 ILA 173.30 -3.45% 32,101

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock